Rabia Kahveci is a director of the International Health Technology Assessment Society (HTAi) and the chair of both the HTAi Developing Countries Interest Group and the Eurasian HTA Initiative. Prior to her position with SAFEMed, she was the director of a hospital-based HTA center in Turkey that covered HTA, innovation for medical devices, and real-world evidence. In Turkey, she also served as a member of the Pharmaceuticals Reimbursement Committee of the Turkish Social Security Institution during the transition to universal health coverage and was a co-author of the reimbursement guidelines; the national clinical quality coordinator of the Turkish Ministry of Health, where she coordinating all activities involving HTA, clinical guidelines, quality, and performance-based payment; and the president of the Turkish Evidence-Based Medicine Society.